FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norbert Schmitz

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Ruth Pettengell; Carmen Ruiz de Elvira; Norbert Schmitz; Rik Schots; Graeme Smith; Christian J Taverna; Herve Tilly; Bik To; Ruzena Uddin; Jan A Walewski; Isabelle Bence-Bruckler; Dolores Caballero; Peter Dreger; Christian H Geisler; Christian Gisselbrecht; Eva Kimby; Tomás Kozák; Bernd Metzner; William N Patton; Anthony H Goldstone
Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Peter Dreger; Michael Hallek; Ute Hegenbart; Michael Kneba; Peter Paschka; Matthias Ritgen; Marianna Rossi; Christof Scheid; Norbert Schmitz; Andrea Schnaiter; Michael Stadler; Sebastian Böttcher; Andreas Bühler; Donald Bunjes; Raymonde Busch; Sascha Dietrich; Hartmut Döhner; Lutz Uharek; Matthias Zeis; Thorsten Zenz; Stephan Stilgenbauer
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Brigitte Mohr; Andreas Neubauer; Uwe Platzbecker; Wolf Rösler; Kerstin Schäfer-Eckart; Markus Schaich; Johannes Schetelig; Norbert Schmitz; Ulrich Schuler; Friedrich Stölzel; Martin Bornhäuser; Gerhard Ehninger; Norbert Frickhofen; Mathias Hänel; Hartmut Link; Jan M Middeke
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norbert Schmitz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ruth Pettengell; Carmen Ruiz de Elvira; Norbert Schmitz; Rik Schots; Graeme Smith; Christian J Taverna; Herve Tilly; Bik To; Ruzena Uddin; Jan A Walewski; Isabelle Bence-Bruckler; Dolores Caballero; Peter Dreger; Christian H Geisler; Christian Gisselbrecht; Eva Kimby; Tomás Kozák; Bernd Metzner; William N Patton; Anthony H Goldstone
Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(13):1624-30.
2013: Peter Dreger; Michael Hallek; Ute Hegenbart; Michael Kneba; Peter Paschka; Matthias Ritgen; Marianna Rossi; Christof Scheid; Norbert Schmitz; Andrea Schnaiter; Michael Stadler; Sebastian Böttcher; Andreas Bühler; Donald Bunjes; Raymonde Busch; Sascha Dietrich; Hartmut Döhner; Lutz Uharek; Matthias Zeis; Thorsten Zenz; Stephan Stilgenbauer
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Blood 2013;121(16):3284-8.
2013: Brigitte Mohr; Andreas Neubauer; Uwe Platzbecker; Wolf Rösler; Kerstin Schäfer-Eckart; Markus Schaich; Johannes Schetelig; Norbert Schmitz; Ulrich Schuler; Friedrich Stölzel; Martin Bornhäuser; Gerhard Ehninger; Norbert Frickhofen; Mathias Hänel; Hartmut Link; Jan M Middeke
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
British journal of haematology 2013;161(2):237-44.
2013: Martin Dreyling; A Gallamini; Olivier Hermine; E Iannitto; J C Kluin-Nelemans; M Ladetto; Steven Le Gouill; S Pileri; J Rodriguez; Norbert Schmitz; C Thieblemont; A Wotherspoon; P Zinzani; L Arcaini; E Campo; E Zucca
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):857-77.
2013: Heike Horn; Michael Hummel; Wolfram Klapper; Markus Loeffler; Peter Möller; German Ott; Michael Pfreundschuh; Andreas Rosenwald; Christopher Schmelter; Norbert Schmitz; Reiner Siebert; Harald Stein; Lorenz Trümper; Marita Ziepert; Thomas F E Barth; Claudia Becher; Heinz-Wolfram Bernd; Sergio B Cogliatti; Alfred C Feller; Martin-Leo Hansmann
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
Blood 2013;121(12):2253-63.
2013: Tamara Alpermann; Claudia Haferlach; Wolfgang Kern; Karl-Anton Kreuzer; Hermann Josef Pielken; Christoph Schmid; Norbert Schmitz; Susanne Schnittger; Hubert Serve; Clemens-Martin Wendtner; Torsten Haferlach
Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemia.
Leukemia research 2013;37(2):197-200.
2013: Susanne Schnittger; P Staib; H-E Wichmann; T Alpermann; C Eder; A Fasan; V Grossmann; Claudia Haferlach; T Illig; S Jeromin; Wolfgang Kern; N Klopp; Alexander Kohlmann; K-A Kreuzer; Rudolf Peceny; C Schmid; Norbert Schmitz; Torsten Haferlach
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
Leukemia 2013;27(1):82-91.
2012: Christian Gisselbrecht; Andre Bosly; Josette Brière; Ulrich Dührsen; Hans Hagberg; Nicolas Ketterer; David C Linch; Ray Lowenthal; David D Ma; Noel J Milpied; Craig H Moskowitz; Nicolas Mounier; John Radford; Gilles SALLES; Norbert Schmitz; Ofer Shpilberg; Devinder Singh Gill; Marek Trneny; Andreas Viardot; Bertram Glaß
Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4462-9.
2012: Norbert Schmitz; Lorenz Truemper; Andreas Viardot; Marita Ziepert; Martin Bentz; Peter Borchmann; Gottfried Doelken; Gerhard Ehninger; Bertram Glaß; Mathias Haenel; Markus Loeffler; Maike Nickelsen; Norma Peter; Michael Pfreundschuh; Andreas Rosenwald; Christian Ruebe; Christian Schmidt
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
The lancet oncology 2012;13(12):1250-9.
2012: J Rose; Norbert Schmitz; S Sesselmann; C Skhirtladze; Stephan Söder; Pia Gebhard; Thomas Aigner
DNA damage, discoordinated gene expression and cellular senescence in osteoarthritic chondrocytes.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2012;20(9):1020-8.
2012: S Pfefferle; Hagen Frickmann; M Gabriel; Stephan Günther; Norbert Schmitz; Jonas Schmidt-Chanasit
Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany.
Infection 2012;40(4):451-4.
2012: Peter Dreger; Ulrich Dührsen; Anna-Maria Fink; Hildegard Greinix; Michael Hallek; Manfred Hensel; Wolfgang Knauf; Michael Kneba; Fabienne McClanahan; Michael Pfreundschuh; Matthias Ritgen; Johannes Schetelig; Norbert Schmitz; Michael Stadler; Stephan Stilgenbauer; Dirk Winkler; Günter Brittinger; Andreas Bühler; Raymonde Busch; Hartmut Döhner
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Blood 2012;119(21):4851-9.
2012: Norbert Schmitz; L Truemper; M Wolf; S Zeynalova; E Cavallin-Stahl; Bertram Glaß; M Haenel; U Kaiser; M Loeffler; Michael Pfreundschuh
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1267-73.
2012: Norbert Schmitz; M Nickelsen; Bertram Glaß
Autologous or allogeneic transplantation in B- and T-cell lymphomas.
Best practice & research. Clinical haematology 2012;25(1):61-73.
2012: Anna Sureda; David Valcárcel; Bianca Xicoy; Lucia López Corral; Jordi Sierra; Reyes Arranz; Joan Besalduch; Mats Brune; Dolores Caballero; Carme Canals; Rafael Duarte; Ana García-Noblejas; Angel León; Rodrigo Martino; Maria Jesus Pascual; Jacob Passweg; Josep Maria Ribera; Norbert Schmitz
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica 2012;97(2):310-7.
2012: Sandra Siegel; Steffi Wirth; Norbert Schmitz; Michaela Schweizer; Matthias Zeis
M-phase phosphoprotein 11 is a highly immunogenic tumor antigen in patients with acute myeloid leukemia.
Acta haematologica 2012;127(4):193-7.
2011: Catherine Thieblemont; Philippe Trougouboff; Hans-Ullrich Voelker; Loic Ysebaert; Ludmila Boudova; Josette Briere; Dominique Bron; Catherine Chevalier; Sergio Cogliatti; Wendy Cuccuini; Philippe Gaulard; Edouard Hirchaud; Remi Houlgatte; Andrew Jack; Nicolas Mounier; Andreas Rosenwald; Norbert Schmitz; Jean Soulier; Christer Sundstrom; Christian Gisselbrecht
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4079-87.
2011: Carsten Zwick; F Hartmann; E Lengfelder; Markus Loeffler; Christina Nickenig; N Peter; Michael Pfreundschuh; V Pöschel; M Reiser; G Schlimok; Norbert Schmitz; J Schubert; S Zeynalova
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(8):1872-7.
2011: Markus Schaich; Johannes Schetelig; Norbert Schmitz; Silke Soucek; Reingard Stuhlmann; Christian Thiede; Joachim Tischler; Hannes Wandt; Anthony Ho; Martin Kaufmann; Alwin Krämer; Michael Kramer; Brigitte Mohr; Uta Oelschlaegel; Christoph Röllig; Kerstin Schäfer-Eckart; Walter Aulitzky; Heinrich Bodenstein; Martin Bornhäuser; Gerhard Ehninger
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2696-702.
2011: Birte Friedrichs; Klaus Heidorn; Dieter Kabelitz; Rudolph Reimer; Norbert Schmitz; Christoph Schulte; Sandra Siegel; Adel L Barsoum; Joseph H Coggin; Matthias Zeis
High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia.
Leukemia research 2011;35(6):721-9.
2011: Sascha Dietrich; Blanca Tielesch; Michael Rieger; Maike Nickelsen; Christiane Pott; Mathias Witzens-Harig; Michael Kneba; Norbert Schmitz; Antony D Ho; Peter Dreger
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
Cancer 2011;117(9):1901-10.
2011: F Stölzel; M Pfirrmann; Walter Aulitzky; M Kaufmann; Heinrich Bodenstein; Martin Bornhäuser; Christoph Röllig; M Kramer; Brigitte Mohr; U Oelschlägel; Norbert Schmitz; Silke Soucek; Christian Thiede; Gerhard Ehninger; Markus Schaich
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.
Leukemia 2011;25(3):420-8.
2010: German Ott; Marita Ziepert; Wolfram Klapper; Heike Horn; Monika Szczepanowski; Heinz-Wolfram Bernd; Christoph Thorns; Alfred C Feller; Dido Lenze; Michael Hummel; Harald Stein; Hans Konrad Müller-Hermelink; Matthias Frank; Martin-Leo Hansmann; Thomas F E Barth; Peter Möller; Sergio B Cogliatti; Michael Pfreundschuh; Norbert Schmitz; Lorenz Trümper; Markus Loeffler; Andreas Rosenwald
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.
Blood 2010;116(23):4916-25.
2010: Andreas Josting; Horst Müller; Peter Borchmann; Joke W Baars; B Metzner; Hartmut Döhner; Igor Aurer; Lenka Smardova; Thomas Fischer; Dietger Niederwieser; Kerstin Schäfer-Eckart; Norbert Schmitz; Anna Sureda; Jan-Peter Glossmann; Volker Diehl; Daphne DeJong; Martin-Leo Hansmann; John Raemaekers; Andreas Engert
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(34):5074-80.
2010: Charalampia Kyriakou; Carmen Canals; Jan J Cornelissen; Gerard Socié; Roel Willemze; Norbert Ifrah; Hildegard T Greinix; Didier Blaise; Eric Deconinck; Augustin Ferrant; Anton Schattenberg; Jean-Luc Harousseau; Anna Sureda; Norbert Schmitz
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4926-34.
2010: Norbert Schmitz; Lorenz Trümper; Marita Ziepert; Maike Nickelsen; Anthony D Ho; Bernd Metzner; Norma Peter; Markus Loeffler; Andreas Rosenwald; Michael Pfreundschuh
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Blood 2010;116(18):3418-25.
2010: Bertram Glaß; M Ziepert; M Reiser; M Freund; L Trümper; B Metzner; A Feller; Markus Loeffler; Michael Pfreundschuh; Norbert Schmitz
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2255-61.
2010: Rafael F Duarte; Carmen Canals; Francesco Onida; Ian H Gabriel; Reyes Arranz; William Arcese; Augustin Ferrant; Guido Kobbe; Franco Narni; Giorgio Lambertenghi Deliliers; Eduardo Olavarría; Norbert Schmitz; Anna Sureda
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4492-9.
2010: Peter Dreger; Hartmut Döhner; Matthias Ritgen; S Böttcher; Raymonde Busch; Sascha Dietrich; Donald Bunjes; Sandra Cohen; Jörg Schubert; Ute Hegenbart; Dietrich W Beelen; Matthias Zeis; Michael Stadler; Justin Hasenkamp; Lutz Uharek; Christof Scheid; Andreas Humpe; Thorsten Zenz; Dirk Winkler; Michael Hallek; Michael Kneba; Norbert Schmitz; Stephan Stilgenbauer
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.
Blood 2010;116(14):2438-47.
2010: Norbert Schmitz; S Laverty; V B Kraus; Thomas Aigner
Basic methods in histopathology of joint tissues.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2010;18 Suppl 3():S113-6.
2010: Christian Gisselbrecht; Bertram Glaß; Nicolas Mounier; Devinder Singh Gill; David C Linch; Marek Trneny; André Bosly; Nicolas Ketterer; Ofer Shpilberg; Hans Hagberg; David Ma; Josette Brière; Craig Moskowitz; Norbert Schmitz
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4184-90.
2010: S Siegel; S Wirth; D Kabelitz; Norbert Schmitz; Matthias Zeis
Identification of HLA-A*0201-presented T-cell epitopes derived from the tumor-associated antigen M-phase phosphoprotein II in patients with acute myeloid leukemia.
Leukemia 2010;24(9):1660-2.
2010: Marita Ziepert; Dirk Hasenclever; Evelyn Kuhnt; Bertram Glaß; Norbert Schmitz; Michael Pfreundschuh; Markus Loeffler
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2373-80.
2010: Charalampia Kyriakou; Carmen Canals; David Sibon; Jean Yves Cahn; Majid Kazmi; William Arcese; Karin Kolbe; Norbert-Claude Gorin; Kristy Thomson; Noel Milpied; Dietger Niederwieser; Karel Indrák; Paolo Corradini; Anna Sureda; Norbert Schmitz
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2227-32.
2010: Birte Friedrichs; André Tichelli; Andrea Bacigalupo; Nigel H Russell; Tapani Ruutu; Michael Y Shapira; Meral Beksac; Dirk Hasenclever; Gérard Socié; Norbert Schmitz
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.
The lancet oncology 2010;11(4):331-8.
2010: Justin Hasenkamp; Andrea Borgerding; Gerald Wulf; Norbert Schmitz; Lorenz Truemper; Bertram Glaß
Relevance of target cell-induced apoptosis as mechanism of resistance against natural killer cells.
Annals of hematology 2010;89(4):341-8.
2009: Richard Koch; Christian Mensing; Norbert Schmitz; Matthias Zeis; Elaine S Jaffe; Christian Sander
Cutaneous gamma/delta T-cell lymphoma.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2009;7(12):1065-7.
2009: M Nickelsen; M Ziepert; S Zeynalova; Bertram Glaß; B Metzner; M Leithaeuser; H K Mueller-Hermelink; Michael Pfreundschuh; Norbert Schmitz
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(12):1977-84.
2009: Norbert Schmitz; Anna Sureda; Giorgio Dini; Alexander Claviez
Allogeneic transplantation for children and adolescents with Hodgkin lymphoma.
Blood 2009;114(20):4605-6.
2009: Heinz-Wolfram Bernd; Marita Ziepert; Christoph Thorns; Wolfram Klapper; Hans-Heinrich Wacker; Michael Hummel; Harald Stein; Martin-Leo Hansmann; German Ott; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas F E Barth; Peter Möller; Sergio B Cogliatti; Michael Pfreundschuh; Norbert Schmitz; Lorenz Trümper; Silvia Höller; Markus Loeffler; Alfred C Feller
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
Haematologica 2009;94(11):1569-80.
2009: Alexander Claviez; Carme Canals; Daan Dierickx; Jerry Stein; Isabel Badell; Andrea Pession; Stephen Mackinnon; Shimon Slavin; Jean-Hugues Dalle; Manuel Jurado Chacón; Mahmoud Sarhan; Robert Francis Wynn; Meinolf Suttorp; Giorgio Dini; Anna Sureda; Norbert Schmitz
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(10):2060-7.
2009: Norbert Schmitz; Samira Zeynalova; Markus Loeffler; Michael Pfreundschuh
Response: Intrathecal methotrexate and central nervous system events.
Blood 2009;114(9):1999-2000.
2009: Charalampia Kyriakou; Carmen Canals; Jürgen Finke; Guido Kobbe; Jean-Luc Harousseau; Hans-Jochem Kolb; Nicolas Novitzky; Anthony H Goldstone; Anna Sureda; Norbert Schmitz
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3951-8.
2009: José L Díez-Martín; Pascual Balsalobre; Alessandro Re; Mariagrazia Michieli; José M Ribera; Carmen Canals; Eulogio Conde; Anne Rosselet; Ian Gabriel; Rosario Varela; Bernardino Allione; Kate Cwynarski; Philippe Genet; Ildefonso Espigado; Pierre Biron; Norbert Schmitz; Anne E Hunter; Augustin Ferrant; Gaelle Guillerm; Mark Hentrich; Manuel Jurado; Pascual Fernández; David Serrano; Giuseppe Rossi; Anna Sureda
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.
Blood 2009;113(23):6011-4.
2009: Volkmar Boehme; Norbert Schmitz; Samira Zeynalova; Markus Loeffler; Michael Pfreundschuh
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Blood 2009;113(17):3896-902.
2009: Martin Kornacker; J Stumm; Christiane Pott; S Dietrich; S Süssmilch; Manfred Hensel; M Nickelsen; Mathias Witzens-Harig; Michael Kneba; Norbert Schmitz; Anthony Ho; Peter Dreger
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):722-8.
2009: Stephen P Robinson; Anna Sureda; Carmen Canals; Nigel Russell; Dolores Caballero; Andrea Bacigalupo; Arturo Iriondo; Gordon Cook; Andrew Pettitt; Gerard Socie; Francesca Bonifazi; Alberto Bosi; Mauricette Michallet; Effie Liakopoulou; Johan Maertens; Jakob Passweg; Fiona Clarke; Rodrigo Martino; Norbert Schmitz
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome.
Haematologica 2009;94(2):230-8.
2009: Joerg Halter; Yoshihisa Kodera; Alvaro Urbano Ispizua; Hildegard T Greinix; Norbert Schmitz; Geneviève Favre; Helen Baldomero; Dietger Niederwieser; Jane F Apperley; Alois Gratwohl
Severe events in donors after allogeneic hematopoietic stem cell donation.
Haematologica 2009;94(1):94-101.
2009: Peter Reimer; Thomas Rüdiger; Eva Geissinger; Florian Weissinger; Christoph Nerl; Norbert Schmitz; Andreas Engert; Hermann Einsele; Hans Konrad Müller-Hermelink; Martin Wilhelm
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):106-13.
2008: Johannes Schetelig; Anja van Biezen; Ronald Brand; Dolores Caballero; Rodrigo Martino; Maija Itala; José A García-Marco; Liisa Volin; Norbert Schmitz; Rainer Schwerdtfeger; Arnold Ganser; Francesco Onida; Brigitte Mohr; Stephan Stilgenbauer; Martin Bornhäuser; Theo de Witte; Peter Dreger
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5094-100.
2008: Alexander Claviez; A Sureda; Norbert Schmitz
Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
Bone marrow transplantation 2008;42 Suppl 2():S16-24.
2008: Norbert Schmitz
Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 5():v63-7.
2008: Matthias Ritgen; S Böttcher; S Stilgenbauer; D Bunjes; J Schubert; S Cohen; A Humpe; M Hallek; M Kneba; Norbert Schmitz; H Döhner; P Dreger
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
Leukemia 2008;22(7):1377-86.
2008: Birte Friedrichs; Sandra Siegel; Marita Kloess; Adel Barsoum; Joseph Coggin; James Rohrer; Ilja Jakob; Markus Tiemann; Klaus Heidorn; Christoph Schulte; Dieter Kabelitz; Jörg Steinmann; Norbert Schmitz; Matthias Zeis
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):6374-84.
2008: Jorg Basecke; Martina Podleschny; Annegret Becker; Edda Seiffert; Ivonne Schwiers; Roman Schwiers; Detlef Haase; Bertram Glaß; Norbert Schmitz; Lorenz Trumper; Frank Griesinger
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
British journal of haematology 2008;141(1):52-9.
2008: R F Duarte; Norbert Schmitz; O Servitje; A Sureda
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
Bone marrow transplantation 2008;41(7):597-604.
2008: Nigel Russell; Rolf Mesters; Joerg Schubert; Marc Boogaerts; Hans E Johnsen; Consuelo Del Canizo; Nigel Baker; Philippa Barker; Tomas Skacel; Norbert Schmitz
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Haematologica 2008;93(3):405-12.
2008: Michael Pfreundschuh; Carsten Zwick; S Zeynalova; U Dührsen; K-H Pflüger; T Vrieling; R Mesters; H-G Mergenthaler; H Einsele; Martin Bentz; E Lengfelder; Lorenz Trümper; C Rübe; Norbert Schmitz; Markus Loeffler
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):545-52.
2008: Michael Pfreundschuh; Joerg Schubert; Marita Ziepert; Rudolf Schmits; Martin Mohren; Eva Lengfelder; Marcel Reiser; Christina Nickenig; Michael Clemens; Norma Peter; Carsten Bokemeyer; Hartmut Eimermacher; Anthony Ho; Martin Hoffmann; Roland Mertelsmann; Lorenz Trümper; Leopold Balleisen; Ruediger Liersch; Bernd Metzner; Frank Hartmann; Bertram Glaß; Viola Poeschel; Norbert Schmitz; Christian Ruebe; Alfred C Feller; Markus Loeffler
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
The lancet oncology 2008;9(2):105-16.
2008: Anna Sureda; Stephen Robinson; Carme Canals; Angelo M Carella; Marc A Boogaerts; Dolores Caballero; Ann E Hunter; Lothar Kanz; Shimon Slavin; Jan J Cornelissen; Martin Gramatzki; Dietger Niederwieser; Nigel H Russell; Norbert Schmitz
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):455-62.
2008: Charalampia Kyriakou; Carme Canals; Anthony Goldstone; Dolores Caballero; Bernd Metzner; Guido Kobbe; Hans-Jochem Kolb; Joachim Kienast; Peter Reimer; Jurgen Finke; Gunnar Oberg; Ann Hunter; Niklas Theorin; Anna Sureda; Norbert Schmitz
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):218-24.
2007: Norbert Schmitz; Peter Dreger; Bertram Glaß; Anna Sureda
Allogeneic transplantation in lymphoma: current status.
Haematologica 2007;92(11):1533-48.
2007: Silvia Montoto; C Canals; Ama Z S Rohatiner; Goli Taghipour; A Sureda; Norbert Schmitz; Christian Gisselbrecht; L Fouillard; Noël Milpied; C Haioun; S Slavin; E Conde; Christophe Fruchart; A Ferrant; V Leblond; Hervé Tilly; T A Lister; Anthony H Goldstone
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
Leukemia 2007;21(11):2324-31.
2007: Norbert Schmitz; Christian Buske; Christian Gisselbrecht
Autologous stem cell transplantation in lymphoma.
Seminars in hematology 2007;44(4):234-45.
2007: Georgia Metzgeroth; Christoph Walz; Joannah Score; R Siebert; S Schnittger; Claudia Haferlach; H Popp; Torsten Haferlach; Philipp Erben; J Mix; Martin C Müller; H Beneke; L Müller; F Del Valle; Walter Aulitzky; G Wittkowsky; Norbert Schmitz; C Schulte; K Müller-Hermelink; E Hodges; S J Whittaker; F Diecker; H Döhner; P Schuld; Rüdiger Hehlmann; Andreas Hochhaus; Nicholas C P Cross; Andreas Reiter
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Leukemia 2007;21(6):1183-8.
2007: Peter Dreger; Norbert Schmitz
Autologous stem cell transplantation as part of first-line treatment of Waldenström's macroglobulinemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):623-4.
2007: Peter Dreger; Michael Rieger; Bärbel Seyfarth; Manfred Hensel; Michael Kneba; Anthony Ho; Norbert Schmitz; Christiane Pott
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
Haematologica 2007;92(1):42-9.
2007: V Boehme; S Zeynalova; Marita Kloess; Markus Loeffler; U Kaiser; Michael Pfreundschuh; Norbert Schmitz
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):149-57.
2006: Norbert Schmitz; Mary Eapen; Mary M Horowitz; Mei-Jie Zhang; John P Klein; J Douglas Rizzo; Fausto R Loberiza; Alois Gratwohl; Richard E Champlin
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Blood 2006;108(13):4288-90.
2006: Birte Friedrichs; Markus Tiemann; Hans Salwender; Karl Verpoort; Michael K Wenger; Norbert Schmitz
The effects of rituximab treatment during pregnancy on a neonate.
Haematologica 2006;91(10):1426-7.
2006: Birte Friedrichs; Sandra Siegel; Mads Hald Andersen; Norbert Schmitz; Matthias Zeis
Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies.
Leukemia & lymphoma 2006;47(6):978-85.
2006: Sandra Siegel; Andreas Wagner; Birte Friedrichs; Anneke Wendeler; Lena Wendel; Dieter Kabelitz; Jörg Steinmann; Adel L Barsoum; Joseph H Coggin; James Rohrer; Peter Dreger; Norbert Schmitz; Matthias Zeis
Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(11):6935-44.
2006: Bertram Glaß; Marita Kloess; Martin Bentz; Günter Schlimok; Wolfgang E Berdel; Alfred Feller; Lorenz Trümper; Markus Loeffler; Michael Pfreundschuh; Norbert Schmitz
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
Blood 2006;107(8):3058-64.
2006: Andreas Engert; Henning Bredenfeld; Hartmut Döhner; Anthony Ho; Norbert Schmitz; Dietmar Berger; Pamela Bacon; Tomas Skacel; Valerie Easton; Volker Diehl
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica 2006;91(4):546-9.
2006: Bärbel Seyfarth; Andreas Josting; Martin Dreyling; Norbert Schmitz
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.
British journal of haematology 2006;133(1):3-18.
2006: Per Ljungman; Alvaro Urbano-Ispizua; M Cavazzana-Calvo; Taner Demirer; G Dini; H Einsele; A Gratwohl; A Madrigal; Dietger Niederwieser; Jakob Passweg; Vanderson Rocha; Riccardo Saccardi; H Schouten; Norbert Schmitz; Gerard Socie; A Sureda; Jane Apperley
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2006;37(5):439-49.
2006: Christian Hoffmann; R Repp; Robert Schoch; Benedikt Gahn; N Schub; C Beck; Andreas Humpe; M Kneba; Heinz-August Horst; Norbert Schmitz; Martin Gramatzki
Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma.
European journal of medical research 2006;11(2):73-6.
2006: Norbert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E Berdel; Bernd Metzner; Bernd Dorken; Michael Kneba; Lorenz Trumper; Markus Loeffler; Michael Pfreundschuh; Bertram Glaß
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Cancer 2006;106(1):136-45.
2005: Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood 2005;106(12):3725-32.
2005: Peter Dreger; Matthias Ritgen; Sebastian Böttcher; Norbert Schmitz; Michael Kneba
The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?
Leukemia 2005;19(7):1135-8.
2005: Norbert Schmitz; A Sureda
The role of allogeneic stem-cell transplantation in Hodgkin's disease.
European journal of haematology. Supplementum 2005;(66):146-9.
2005: Bernd Hertenstein; Lothar Hambach; Andrea Bacigalupo; Norbert Schmitz; Shaun McCann; Shimon Slavin; Alois Gratwohl; Augustin Ferrant; Ahmet H Elmaagacli; Rainer Schwertfeger; Anna Locasciulli; Axel Zander; Martin Bornhäuser; Dietger Niederwieser; Tapani Ruutu
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2005;90(7):969-75.
2005: Norbert Schmitz
Does hematopoietic stem cell transplantation improve patient outcome in juvenile myelomonocytic leukemia?
Nature clinical practice. Oncology 2005;2(6):294-5.
2005: Norbert Schmitz; Meral Beksac; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; Jane Apperley; Jeff Szerm; Kenneth F Bradstock; Agnès Buzyn; Brigitte Schlegelberger; James Matcham; Alois Gratwohl
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Haematologica 2005;90(5):643-8.
2005: Ruth Sonnen; Wolf-Peter Schmidt; Hans Konrad Müller-Hermelink; Norbert Schmitz
The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas.
British journal of haematology 2005;129(3):366-72.
2005: Rudolf Schmits; Norbert Schmitz; Michael Pfreundschuh
The best treatment for diffuse large B-cell lymphoma: a German perspective.
Oncology (Williston Park, N.Y.) 2005;19(4 Suppl 1):16-25.
2005: Norbert Schmitz
The role of thrombopoetin in growing hematopoietic stem cells.
Haematologica 2005;90(2):145.
2005: Norbert Schmitz
Cytotoxic drugs, collection of stem cells and hematologic recovery after autologous transplantation.
Haematologica 2005;90(1):4-5.
2005: Tapani Ruutu; P Corradini; Alois Gratwohl; E Holler; J Apperley; G Dini; V Rocha; Norbert Schmitz; Gérard Socié; Dietger Niederwieser
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2005;35(2):121-4.
2004: Norbert Schmitz; P Ljungman; C Cordonnier; C Kempf; W Linkesch; Adrián Alegre; Carlos Solano; B Simonsson; R Sonnen; V Diehl; T Fischer; Dolores Caballero; T Littlewood; R Noppeney; P Schafhausen; L Jost; F Delabarre; R Marcus
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
Bone marrow transplantation 2004;34(11):955-62.
2004: Sandra Siegel; Jörg Steinmann; Norbert Schmitz; R Stuhlmann; Peter Dreger; Matthias Zeis
Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes.
Leukemia 2004;18(12):2046-7.
2004: Georg Lenz; Martin Dreyling; Eva Schiegnitz; Roswitha Forstpointner; Hannes Wandt; Mathias Freund; Georg Hess; Lorenz Truemper; Volker Diehl; Martin Kropff; Michael Kneba; Norbert Schmitz; Bernd Metzner; Markus Pfirrmann; Michael Unterhalt; Wolfgang Hiddemann
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
Blood 2004;104(9):2667-74.
2004: Matthias Ritgen; Stephan Stilgenbauer; Nils von neuhoff; Andreas Humpe; Monika Brüggemann; Christiane Pott; Thorsten Raff; Alexander Kröber; Donald Bunjes; Richard F Schlenk; Norbert Schmitz; Hartmut Döhner; Michael Kneba; Peter Dreger
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Blood 2004;104(8):2600-2.
2004: Bertram Glaß; M Nickelsen; Peter Dreger; Alexander Claviez; Justin Hasenkamp; Gerald Wulf; Lorenz Trümper; Norbert Schmitz
Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect.
Bone marrow transplantation 2004;34(5):391-7.
2004: Wolf-Peter Schmidt; Norbert Schmitz; Ruth Sonnen
Conservative management of gastric lymphoma: the treatment option of choice.
Leukemia & lymphoma 2004;45(9):1847-52.
2004: Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rübe; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Hartmut Eimermacher; Dirk Hasenclever; Norbert Schmitz; Markus Loeffler
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Blood 2004;104(3):634-41.
2004: Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Bernd Metzner; Dirk Hasenclever; Norbert Schmitz; Bertram Glaß; Christian Rübe; Markus Loeffler
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Blood 2004;104(3):626-33.
2004: Clifford Hudis; Norbert Schmitz
Dose-dense chemotherapy in breast cancer and lymphoma.
Seminars in oncology 2004;31(3 Suppl 8):19-26.
2004: Peter Dreger; Stephan Stilgenbauer; Axel Benner; Matthias Ritgen; Alexander Kröber; Michael Kneba; Norbert Schmitz; Hartmut Döhner
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Blood 2004;103(7):2850-8.
2004: Alexander Claviez; Thomas Klingebiel; Jörg Beyer; Wenzel Nürnberger; Gerhard Ehninger; Meinolf Suttorp; Peter Dreger; Wolfgang Dörffel; Norbert Schmitz
Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.
Annals of hematology 2004;83(4):237-41.
2004: Norbert Schmitz; Anna Sureda; Stephen Robinson
Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin's disease: indications and results.
Seminars in oncology 2004;31(1):27-32.
2004: Peter Reimer; Tobias Schertlin; Thomas Rüdiger; Eva Geissinger; Sabine Roth; Volker Kunzmann; Florian Weissinger; Christoph Nerl; Norbert Schmitz; Hans Konrad Müller-Hermelink; Martin Wilhelm
Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):304-11.
2004: B Weiss; M Hoffmann; Christof Anders; Peter Hellstern; Norbert Schmitz; Michael Uppenkamp
Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
Annals of hematology 2004;83(1):44-9.
2003: Sandra Siegel; Andreas Wagner; Dieter Kabelitz; Matthias Marget; Joseph H Coggin; Adel L Barsoum; James Rohrer; Norbert Schmitz; Matthias Zeis
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Blood 2003;102(13):4416-23.
2003: G Favre; M Beksaç; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; J Apperley; Jeff Szer; Kenneth F Bradstock; Agnès Buzyn; James Matcham; Alois Gratwohl; Norbert Schmitz
Differences between graft product and donor side effects following bone marrow or stem cell donation.
Bone marrow transplantation 2003;32(9):873-80.
2003: Philip J Bierman; John W Sweetenham; Fausto R Loberiza; Goli Taghipour; Hillard M Lazarus; J Douglas Rizzo; Norbert Schmitz; Koen van Besien; Julie M Vose; Mary Horowitz; Anthony Goldstone
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3744-53.
2003: Sandra Siegel; Andreas Wagner; Norbert Schmitz; Matthias Zeis
Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model.
British journal of haematology 2003;122(6):911-4.
2003: Uwe Platzbecker; Gerhard Ehninger; Norbert Schmitz; Martin Bornhäuser
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.
Annals of hematology 2003;82(8):463-8.
2003: Gernot Hartung; Matthias Zeis; Bertram Glaß; Peter Dreger; Jörg Steinmann; Norbert Schmitz; Lutz Uharek
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Bone marrow transplantation 2003;32(1):49-56.
2003: Nicolaus Kröger; Hermann Einsele; Daniel Wolff; Jochen Casper; Mathias Freund; Günter Derigs; Hannes Wandt; K Schäfer-Eckart; Georg Wittkowsky; Norbert Schmitz; William H Krüger; Tatjana Zabelina; Helmut Renges; Francis Ayuk; Andreas Krüll; Axel Zander
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Bone marrow transplantation 2003;31(11):973-9.
2003: Matthias Zeis; Sandra Siegel; Andreas Wagner; Marc Schmitz; Matthias Marget; Rita Kühl-Burmeister; Ilse Adamzik; Dieter Kabelitz; Peter Dreger; Norbert Schmitz; Axel Heiser
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(11):5391-7.
2003: Carsten Schneider; Edda Bahlmann; Christoph Heuser; Matthias Antz; Oliver Kron; Norbert Schmitz; Karl-Heinz Kuck
Images in cardiovascular medicine. Unusual biventricular thrombus formation in acute myeloid leukemia and factor V Leiden mutation.
Circulation 2003;107(17):e114-6.
2003: Alois Gratwohl; Helen Baldomero; Jakob Passweg; F Frassoni; Dietger Niederwieser; Norbert Schmitz; Alvaro Urbano-Ispizua
Hematopoietic stem cell transplantation for hematological malignancies in Europe.
Leukemia 2003;17(5):941-59.
2003: Andrew J Peniket; M C Ruiz de Elvira; Goli Taghipour; C Cordonnier; E Gluckman; T de Witte; G Santini; D Blaise; H Greinix; A Ferrant; J Cornelissen; Norbert Schmitz; Anthony H Goldstone
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Bone marrow transplantation 2003;31(8):667-78.
2003: Elisabeth Vandenberghe; Carmen Ruiz de Elvira; Fausto R Loberiza; E Conde; A López-Guillermo; C Gisselbrecht; françois guilhot; Julie M Vose; Koen van Biesen; J Douglas Rizzo; Dennis D Weisenburger; Peter Isaacson; Mary M Horowitz; Anthony H Goldstone; Hillard M Lazarus; Norbert Schmitz
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
British journal of haematology 2003;120(5):793-800.
2003: Anna Sureda; Norbert Schmitz
Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies.
Annals of hematology 2003;82(1):1-13.
2003: Jan Stritzke; Tim Zunkel; Jörg Steinmann; Norbert Schmitz; Lutz Uharek; Matthias Zeis
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
British journal of haematology 2003;120(1):27-35.
2002: Stephen P Robinson; Anthony H Goldstone; Stephen Mackinnon; Angelo Carella; Nigel Russell; Carmen Ruiz de Elvira; Goli Taghipour; Norbert Schmitz
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.
Blood 2002;100(13):4310-6.
2002: Ruth Sonnen; Wolf-Peter Schmidt; Rolf Kuse; Norbert Schmitz
Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity.
British journal of haematology 2002;119(3):634-9.
2002: Nicolaus Kröger; Herbert G Sayer; Rainer Schwerdtfeger; Michael Kiehl; Arnon Nagler; Helmut Renges; Tatjana Zabelina; Boris Fehse; Francis Ayuk; Georg Wittkowsky; Norbert Schmitz; Axel R Zander
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
2002: Ulrich Kaiser; Irmgard Uebelacker; Ulrich Abel; Josef Birkmann; Lorenz Trümper; Harald Schmalenberg; Tunca Karakas; Bernd Metzner; Dieter K Hossfeld; Helge G Bischoff; Astrid Franke; Marcel Reiser; Peter Müller; Luisa Mantovani; Marc Grundeis; Frank Rothmann; Cay-Uwe von Seydewitz; Rolf M Mesters; Ernst U Steinhauer; Dorothea Krahl; Kurt Schumacher; Michael Kneba; Baudis Michael; Norbert Schmitz; Rüdiger Pfab; Hubert Köppler; Reza Parwaresch; Michael Pfreundschuh; Klaus Havemann
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4413-9.
2002: Norbert Schmitz; Meral Beksac; Dirk Hasenclever; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; Jane F Apperley; Norbert-Claude Gorin; Jeff Szer; Kenneth F Bradstock; Agnès Buzyn; Peter Clark; Keith Borkett; Alois Gratwohl
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Blood 2002;100(3):761-7.
2002: Norbert Schmitz; Beate Pfistner; Michael Sextro; Markus Sieber; Angelo M Carella; Matthias Haenel; Friederike Boissevain; Reinhart Zschaber; Peter Müller; Hartmut Kirchner; Andreas Lohri; Susanne Decker; Bettina Koch; Dirk Hasenclever; Anthony H Goldstone; Volker Diehl
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
Lancet 2002;359(9323):2065-71.
2002: Alvaro Urbano-Ispizua; Norbert Schmitz; T de Witte; F Frassoni; G Rosti; Hubert Schrezenmeier; E Gluckman; W Friedrich; C Cordonnier; Gerard Socie; A Tyndall; D Niethammer; Per Ljungman; A Gratwohl; Jane Apperley; Dietger Niederwieser; A Bacigalupo
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2002;29(8):639-46.
2002: Matthias Zeis; Tim Zunkel; Jörg Steinmann; Norbert Schmitz; Lutz Uharek
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
British journal of haematology 2002;117(1):93-102.
2002: panos kottaridis; Karl S Peggs; Norbert Schmitz; P Dreger; M A Boogaerts; Augustin Ferrant; Hilde Demuynck; A Zander; H Link; J Matcham; David C Linch; Keith Borkett; Anthony H Goldstone
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
Leukemia & lymphoma 2002;43(3):531-6.
2002: R Champlin; Charles Hesdorffer; B Lowenberg; M F Martelli; R H Mertelsmann; Y Reisner; Norbert Schmitz
Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.
Leukemia 2002;16(3):427-8.
2002: Matthias Zeis; H Frenzke; Norbert Schmitz; Lutz Uharek; Jörg Steinmann
Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Bone marrow transplantation 2002;29(3):213-21.
2002: Anna Sureda; Norbert Schmitz
Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():128-32.
2002: Norbert Schmitz; John Barrett
Optimizing engraftment--source and dose of stem cells.
Seminars in hematology 2002;39(1):3-14.
2001: H D Ottinger; C R Müller; S F Goldmann; E Albert; R Arnold; D W Beelen; R Blasczyk; D Bunjes; J Casper; W Ebell; G Ehninger; Thomas Eiermann; H Einsele; A Fauser; S Ferencik; J Finke; B Hertenstein; A Heyll; T Klingebiel; A Knipper; B Kremens; H J Kolb; K Kolbe; E Lenartz; M Lindemann; C A Müller; J Mytilineos; Dietger Niederwieser; V Runde; H Sayer; U W Schaefer; Norbert Schmitz; S Schröder; R Schulze-Rath; R Schwerdtfeger; W Siegert; Bernhard Thiele; A R Zander; H Grosse-Wilde
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
Annals of hematology 2001;80(12):706-14.
2001: Bärbel Seyfarth; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Norbert Schmitz; Peter Dreger
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Annals of hematology 2001;80(7):398-405.
2001: Norbert Schmitz
Rituximab in autologous stem cell transplantation for follicular lymphoma.
Anti-cancer drugs 2001;12 Suppl 2():S21-4.
2001: John W Sweetenham; G Santini; Wendi Qian; M Guelfi; Norbert Schmitz; SJ Simnett; A Nagler; Harald Holte; Stein Kvaloy; P Bruzzi; Anthony H Goldstone
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2927-36.
2001: Michael Pfreundschuh; Dirk Hasenclever; Markus Loeffler; G Ehninger; Norbert Schmitz; Hartmut Kirchner; Peter Koch; Bernd Lathan; Ulrich Rueffer; Michael Sextro; Jeremy Franklin; Hans Tesch; Volker Diehl
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):471-7.
2001: Paolo Anderlini; J Douglas Rizzo; M L Nugent; Norbert Schmitz; Richard E Champlin; Mary M Horowitz
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
Bone marrow transplantation 2001;27(7):689-92.
2001: Peter Dreger; Norbert Schmitz
Allogeneic transplantation of blood stem cells: coming of age?
Annals of hematology 2001;80(3):127-36.
2001: Matthias Zeis; Jörg Steinmann; E Petrela; Gernot Hartung; Norbert Schmitz; Lutz Uharek
Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
Bone marrow transplantation 2001;27(3):279-85.
2001: C D Williams; C N Harrison; T A Lister; A J Norton; A K Blystad; Bertrand Coiffier; Goli Taghipour; Norbert Schmitz; Anthony H Goldstone
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):727-35.
2001: Norbert Schmitz
6. Report on workshop: EBMT workshop "High dose therapy in aggressive NHL".
Annals of hematology 2001;80 Suppl 3():B24-5.
2001: Matthias Zeis; Lutz Uharek; Gernot Hartung; Bertram Glaß; Jörg Steinmann; Norbert Schmitz
Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(2):136-44.
2000: Peter Dreger; Bertram Glaß; Bärbel Seyfarth; Andreas Humpe; Alexander Claviez; Nils von neuhoff; Meinolf Suttorp; Robert Schoch; Norbert Schmitz
Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.
Bone marrow transplantation 2000;26(12):1361-2.
2000: Olle Ringdén; Myriam Labopin; Norbert-Claude Gorin; Norbert Schmitz; UW Schaefer; H G Prentice; L Bergmann; Jean-Pierre Jouet; F Mandelli; D Blaise; Loïc Fouillard; Francesco Frassoni
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
British journal of haematology 2000;111(4):1130-7.
2000: Peter Dreger; K Viehmann; Nils von neuhoff; D Krüss; Bertram Glaß; Michael Kneba; Peggie Mitsky; P Jopp; Peter Rautenberg; B Mills; Norbert Schmitz
A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia.
Experimental hematology 2000;28(10):1187-96.
2000: Hellmut D Ottinger; C Müller; Norbert Schmitz; B Kubanek; Renate Arnold; Wolfram Ebell; H P Eberhard; Gerhard Ehninger; U Fronz; Shraga F Goldmann; Hans Grosse-Wilde; Werner Havers; Thomas Klingebiel; Hans-Jochem Kolb; Siegfried Seeber; Ulrich W Schaefer; H Baldomero; Alois Gratwohl
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
2000: C Lehmann; Matthias Zeis; Norbert Schmitz; Lutz Uharek
Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
Blood 2000;96(2):594-600.
2000: Peter Dreger; Peter Rautenberg; Michael Kneba; Norbert Schmitz
Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC.
Bone marrow transplantation 2000;26(1):114-6.
2000: Richard E Champlin; Norbert Schmitz; Mary M Horowitz; B Chapuis; R Chopra; J J Cornelissen; Robert Peter Gale; John M Goldman; Fausto R Loberiza; B Hertenstein; John P Klein; E Montserrat; Mei-Jie Zhang; Olle Ringdén; Sandra C Tomany; Philip Rowlings; M E Van Hoef; Alois Gratwohl
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2000;95(12):3702-9.
2000: Peter Dreger; S Martin; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Nicolaus Kröger; Reza Parwaresch; Michael Kneba; Norbert Schmitz; R Haas
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):87-94.
2000: Peter Dreger; M Michallet; Norbert Schmitz
Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():49-53.
1999: John W Sweetenham; A M Carella; Goli Taghipour; D Cunningham; R Marcus; A Della Volpe; D C Linch; Norbert Schmitz; Anthony H Goldstone
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3101-9.
1999: R Walshe; Norbert Schmitz; V Diehl
Can corporatization contribute to quality assurance and cost control in the German hospital sector? A pilot project for stem cell transplantation.
Health policy (Amsterdam, Netherlands) 1999;48(3):207-18.
1999: Donald W Milligan; Mary Carmen Ruiz de Elvira; H J Kolb; Anthony H Goldstone; G Meloni; A Z Rohatiner; P Colombat; Norbert Schmitz
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation.
British journal of haematology 1999;106(4):1020-6.
1999: Peter Dreger; K Viehmann; Nils von neuhoff; T Glaubitz; O Petzoldt; Bertram Glaß; Lutz Uharek; Peter Rautenberg; M Suttorp; B Mills; Peggie Mitsky; Norbert Schmitz
Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Bone marrow transplantation 1999;24(2):153-61.
1999: Peter Dreger; Bertram Glaß; Rolf Kuse; Ruth Sonnen; Nils von neuhoff; H Bolouri; Michael Kneba; Norbert Schmitz
Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia.
British journal of haematology 1999;106(1):115-8.
1999: C Lehmann; Bertram Glaß; Matthias Zeis; Norbert Schmitz; Lutz Uharek
Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1999;48(4):209-13.
1999: V Diehl; R Walshe; Norbert Schmitz
A new approach to safeguard high standards and cost containment of stem cell transplantation in Germany.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):609.
1999: Peter Dreger; Norbert Schmitz
Allogeneic transplantation of peripheral blood stem cells.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):261-78.
1999: Margaret A Shipp; M D Abeloff; Karen Antman; G Carroll; A Hagenbeek; Markus Loeffler; E Montserrat; J A Radford; Gilles SALLES; Norbert Schmitz; M Symann; James O Armitage; T Philip; Bertrand Coiffier
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):423-9.
1999: Margaret A Shipp; M D Abeloff; Karen Antman; G Carroll; A Hagenbeek; Markus Loeffler; E Montserrat; J A Radford; Gilles SALLES; Norbert Schmitz; M Symann; James O Armitage; Bertrand Coiffier; T Philip
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):13-9.
1998: Hans Tesch; Volker Diehl; Bernd Lathan; Dirk Hasenclever; Markus Sieber; U Rüffer; Andreas Engert; Jeremy Franklin; Michael Pfreundschuh; K P Schalk; G Schwieder; G Wulf; Gottfried Dölken; P Worst; Peter Koch; Norbert Schmitz; U Bruntsch; C Tirier; U Müller; Markus Loeffler
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Blood 1998;92(12):4560-7.
1998: Nigel H Russell; A Gratwohl; Norbert Schmitz
Developments in allogeneic peripheral blood progenitor cell transplantation.
British journal of haematology 1998;103(3):594-600.
1998: P Harten; Bärbel Seyfarth; Norbert Schmitz
[Febrile neutropenia: practical aspects].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(10):598-611.
1998: Matthias Zeis; Lutz Uharek; Bertram Glaß; W Vosskötter; Peter Dreger; Norbert Schmitz; Jörg Steinmann
Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Experimental hematology 1998;26(11):1068-73.
1998: Nils von neuhoff; Peter Dreger; M Suttorp; Matthias Marget; Susanne Kell; Norbert Schmitz
Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
Bone marrow transplantation 1998;22(2):161-6.
1998: Norbert Schmitz
[Therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and stem cell transplantation].
Praxis 1998;87(25-26):863-8.
1998: Gernot Hartung; Lutz Uharek; Matthias Zeis; Bertram Glaß; Jörg Steinmann; Peter Dreger; Martin Krönke; Norbert Schmitz
Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone.
Bone marrow transplantation 1998;21 Suppl 3():S16-20.
1998: Bertram Glaß; Lutz Uharek; Gernot Hartung; Matthias Zeis; Jörg Steinmann; Peter Dreger; Martin Krönke; Norbert Schmitz
Immunotherapeutic aspects of allogeneic peripheral progenitor cells.
Bone marrow transplantation 1998;21 Suppl 3():S3-8.
1998: Peter Dreger; Nils von neuhoff; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Lutz Uharek; Robert Schoch; Helmut Löffler; Norbert Schmitz
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
British journal of cancer 1998;77(12):2291-7.
1998: Norbert Schmitz; Andrea Bacigalupo; Dirk Hasenclever; Arnon Nagler; Eliane Gluckman; P Clark; P Bourquelot; H Greinix; N Frickhofen; O Ringdén; A Zander; J F Apperley; C Gorin; Keith Borkett; G Schwab; M Goebel; N H Russell; Alois Gratwohl
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(10):995-1003.
1998: Lutz Uharek; Bertram Glaß; Matthias Zeis; Peter Dreger; Jörg Steinmann; Helmut Löffler; Norbert Schmitz
Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Experimental hematology 1998;26(2):93-9.
1998: John M Goldman; Norbert Schmitz; D Niethammer; A Gratwohl
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(1):1-7.
1997: Bertram Glaß; Ignazio Majolino; Peter Dreger; Rosanna Scimè; A Santoro; S Vasta; M Suttorp; T Haferlach; Norbert Schmitz
Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
Bone marrow transplantation 1997;20(7):533-41.
1997: U Paulus; Norbert Schmitz; K Viehmann; Nils von neuhoff; Peter Dreger
Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Bone marrow transplantation 1997;20(5):415-20.
1997: Meinolf Suttorp; Matthias Ritgen; Nils von neuhoff; Robert Schoch; Norbert Schmitz
Blood on filter paper as a readily available source of bcr-abl rearranged mRNA.
Blood 1997;90(4):1713-5.
1997: Bertram Glaß; Lutz Uharek; Matthias Zeis; Peter Dreger; Helmut Löffler; Jörg Steinmann; Norbert Schmitz
Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.
Blood 1997;90(4):1694-700.
1997: P Anderlini; M Körbling; D Dale; A Gratwohl; Norbert Schmitz; David Stroncek; C Howe; S Leitman; M Horowitz; E Gluckman; S Rowley; Donna Przepiorka; R Champlin
Allogeneic blood stem cell transplantation: considerations for donors.
Blood 1997;90(3):903-8.
1997: Peter Dreger; Bertram Glaß; Lutz Uharek; Matthias Zeis; Norbert Schmitz
Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy.
International journal of hematology 1997;66(1):1-11.
1997: Norbert Schmitz; Volker Diehl
Carmustine and the lungs .
Lancet 1997;349(9067):1712-3.
1997: Peter Dreger; Nils von neuhoff; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Lutz Uharek; H Bartels; Helmut Löffler; Norbert Schmitz
Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):401-3.
1997: Peter Dreger; Norbert Schmitz
The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia.
Leukemia 1997;11 Suppl 2():S42-5.
1997: Matthias Zeis; Lutz Uharek; Bertram Glaß; Jörg Steinmann; Peter Dreger; Winfried Gassmann; Norbert Schmitz
Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.
British journal of haematology 1997;96(4):757-61.
1997: Norbert Schmitz
[Therapy of recurrent high-grade non-Hodgkin's lymphoma].
Der Internist 1997;38(2):143-9.
1997: Meinolf Suttorp; Norbert Schmitz
[Polymerase chain reaction].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(1):37-40.
1997: U Paulus; Peter Dreger; K Viehmann; Nils von neuhoff; Norbert Schmitz
Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.
Stem cells (Dayton, Ohio) 1997;15(4):297-304.
1997: Thomas J Smith; bruce hillner; Norbert Schmitz; D C Linch; P Dreger; A H Goldstone; M A Boogaerts; A Ferrant; H Link; A Zander; Saul Yanovich; R Kitchin; M H Erder
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):5-10.
1996: Norbert Schmitz; A Bacigalupo; M Labopin; Ignazio Majolino; J P Laporte; L Brinch; G Cook; G L Deliliers; A Lange; C Rozman; J Garcia-Conde; J Finke; A Domingo-Albos; A Gratwohl
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 1996;95(4):715-23.
1996: H H Euler; A M Marmont; A Bacigalupo; S Fastenrath; Peter Dreger; MM Hoffknecht; A R Zander; B Schalke; U Hahn; R Haas; Norbert Schmitz
Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation.
Blood 1996;88(9):3621-5.
1996: Lutz Uharek; Matthias Zeis; Bertram Glaß; Jörg Steinmann; Peter Dreger; Winfried Gassmann; Norbert Schmitz; Wolfgang Müller-Ruchholtz
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
Leukemia 1996;10(11):1758-64.
1996: Peter Dreger; Bertram Glaß; Lutz Uharek; Norbert Schmitz
Allogeneic peripheral blood progenitor cells: current status and future directions.
Journal of hematotherapy 1996;5(4):331-7.
1996: Winfried Gassmann; Norbert Schmitz; H Löffler; T De Witte
Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Seminars in hematology 1996;33(3):196-205.
1996: N Russel; A Gratwohl; Norbert Schmitz
The place of blood stem cells in allogeneic transplantation.
British journal of haematology 1996;93(4):747-53.
1996: Rüdiger Hehlmann; Hermann Heimpel; Dieter K Hossfeld; Joerg Hasford; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Hochhaus; A Tichelli; W Fett; Norbert Schmitz; A Reiter; Martin Griesshammer; W Pfeifer; M Bümler; T Kamp; Andreas Tobler; Hartmut Eimermacher; R Kuse; Ute Berger; H Ansari
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S21-4.
1996: M Suttorp; Nils von neuhoff; Markus Tiemann; Peter Dreger; Jürgen Schaub; H Löffer; Reza Parwaresch; Norbert Schmitz
Precast commercial polyacrylamide gels for separation of DNA amplificates by temperature gradient gel electrophoresis: application to clonality analysis of lymphomas.
Electrophoresis 1996;17(4):672-7.
1996: Norbert Schmitz; A Gratwohl; J M Goldman
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1996;17(4):471-7.
1996: Norbert Schmitz; A Bacigalupo; M Labopin; Ignazio Majolino; J P Laporte; L Brinch; G Cook; G Lambertenghi-Deliliers; A Lange; C Rozman; J Garcia-Conde; J Finke; A Domingo-Albos; A Gratwohl
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Bone marrow transplantation 1996;17 Suppl 2():S40-6.
1996: Peter Dreger; K Oberböster; Norbert Schmitz
PBPC grafts from healthy donors: analysis of CD34+ and CD3+ subpopulations.
Bone marrow transplantation 1996;17 Suppl 2():S22-7.
1996: A Gratwohl; Norbert Schmitz
First international symposium on allogeneic peripheral blood precursor cell transplants.
Bone marrow transplantation 1996;17 Suppl 2():S1-3.
1996: Norbert Schmitz; D C Linch; Peter Dreger; A H Goldstone; M A Boogaerts; A Ferrant; H M Demuynck; H Link; A Zander; A Barge
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
Lancet 1996;347(8998):353-7.
1996: Brigitte Schlegelberger; T Zwingers; K Hohenadel; D Henne-Bruns; Norbert Schmitz; Torsten Haferlach; C Tirier; H Bartels; Ruth Sonnen; Rolf Kuse
Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):593-9.
1995: O Ringdén; B Lönnqvist; Hans Hägglund; P Ljungman; A Shanwell; E Lawlor; Norbert Schmitz
Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease.
Bone marrow transplantation 1995;16(6):856-7.
1995: H Link; Norbert Schmitz; A Gratwohl; J Goldman
Standards for specialist units undertaking blood and marrow stem cell transplants--recommendations from the EBMT. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1995;16(6):733-6.
1995: Peter Dreger; M Klöss; B Petersen; Torsten Haferlach; Helmut Löffler; Markus Loeffler; Norbert Schmitz
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Blood 1995;86(10):3970-8.
1995: Peter Dreger; Nils von neuhoff; M Suttorp; Helmut Löffler; Norbert Schmitz
Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads.
Bone marrow transplantation 1995;16(4):627-9.
1995: Norbert Schmitz; Peter Dreger; M Suttorp; E B Rohwedder; Torsten Haferlach; Helmut Löffler; A Hunter; N H Russell
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)
Blood 1995;85(6):1666-72.
1995: Norbert Schmitz; Peter Dreger; A R Zander; Gerhard Ehninger; H Wandt; A A Fauser; H J Kolb; A Zumsprekel; A Martin; T Hecht
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Bone marrow transplantation 1995;15(2):261-6.
1995: Peter Dreger; K Viehmann; Jörg Steinmann; V Eckstein; Wolfgang Müller-Ruchholtz; Helmut Löffler; Norbert Schmitz
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Experimental hematology 1995;23(2):147-54.
1995: Norbert Schmitz
Allogeneic transplantation of peripheral blood progenitor cells.
Nouvelle revue française d'hématologie 1995;37(6):377-9.
1995: Dirk Hasenclever; Norbert Schmitz; Volker Diehl
Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).
Leukemia & lymphoma 1995;15 Suppl 1():47-9.
1994: Peter Dreger; Torsten Haferlach; V Eckstein; S Jacobs; M Suttorp; Helmut Löffler; Wolfgang Müller-Ruchholtz; Norbert Schmitz
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
British journal of haematology 1994;87(3):609-13.
1994: Peter Dreger; M Suttorp; H Löffler; Norbert Schmitz
Influence of G-CSF on NK cell recovery after autologous BMT.
Bone marrow transplantation 1994;13(5):667-8.
1994: Michael Pfreundschuh; U Rueffer; Bernd Lathan; Norbert Schmitz; O Brosteanu; Dirk Hasenclever; R Haas; H Kirchner; Peter Koch; R Kuse
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):580-6.
1994: Meinolf Suttorp; M Rister; Norbert Schmitz
Interferon-alpha-2 (IFN) plus hydroxyurea for treatment of juvenile chronic myelogenous leukemia.
Medical and pediatric oncology 1994;22(5):358-9.
1994: Peter Dreger; Jörg Steinmann; R Drost; V Eckstein; M Suttorp; Wolfgang Müller-Ruchholtz; Helmut Löffler; Norbert Schmitz
Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
Progress in clinical and biological research 1994;389():407-13.
1993: Peter Dreger; P Marquardt; Torsten Haferlach; S Jacobs; T Mülverstedt; V Eckstein; M Suttorp; Helmut Löffler; Wolfgang Müller-Ruchholtz; Norbert Schmitz
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
British journal of cancer 1993;68(5):950-7.
1993: Norbert Schmitz; Bertram Glaß; Peter Dreger; Torsten Haferlach; H A Horst; J Ollech-Chwoyka; M Suttorp; Winfried Gassmann; H Löffler
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.
Annals of hematology 1993;66(5):251-6.
1993: M Suttorp; Norbert Schmitz; Peter Dreger; Jürgen Schaub; Helmut Löffler
Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
Leukemia 1993;7(5):679-87.
1993: M Suttorp; C Sprenger; Peter Dreger; E Sievers; Alexander Claviez; Helmut Löffler; Jürgen Schaub; Norbert Schmitz
Amplification of a Y-chromosomal DNA sequence by the polymerase chain reaction for documentation of residual recipient cells in small samples from bone marrow, peripheral blood and cerebrospinal fluid after bone marrow transplantation.
Electrophoresis 1993;14(3):174-8.
1993: Peter Dreger; M Suttorp; Torsten Haferlach; H Löffler; Norbert Schmitz; W Schroyens
Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation.
Blood 1993;81(5):1404-7.
1993: Peter Dreger; K Grelle; V Eckstein; M Suttorp; Wolfgang Müller-Ruchholtz; Helmut Löffler; Norbert Schmitz
Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
British journal of haematology 1993;83(1):7-13.
1993: Peter Dreger; K Viehmann; Jörg Steinmann; Norbert Schmitz; M Suttorp; V Eckstein; Helmut Löffler; Wolfgang Müller-Ruchholtz
CD48 monoclonal antibody K31 for bone marrow transplantation: T-depleting capacity and influence on hematopoietic progenitors.
Bone marrow transplantation 1993;12 Suppl 3():S13-7.
1992: Norbert Schmitz; M Suttorp; Brigitte Schlegelberger; K Weber-Matthiesen; Markus Tiemann; Ruth Sonnen
The role of the spleen after bone marrow transplantation for primary myelofibrosis.
British journal of haematology 1992;81(4):616-8.
1992: H Löffler; Norbert Schmitz; W Gassmann
Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
Hematology/oncology clinics of North America 1992;6(3):619-31.
1992: H Pechumer; Christine Bender-Götze; J U Walther; T Klingebiel; G Ehninger; Meinolf Suttorp; Norbert Schmitz
[Juvenile chronic leukemia and chronic myelomonocytic leukemia. Experiences with bone marrow transplantation in childhood in 5 cases].
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde 1992;140(5):307-12.
1992: Peter Dreger; Jörg Steinmann; Norbert Schmitz; V Eckstein; Helmut Löffler; Wolfgang Müller-Ruchholtz
CD48 monoclonal antibody K31 for bone marrow transplantation.
Progress in clinical and biological research 1992;377():441-7.
1991: Norbert Schmitz; E Prange; Torsten Haferlach; H Griesser; Ruth Sonnen; Brigitte Schlegelberger; S Claus; Helmut Löffler
High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD).
Bone marrow transplantation 1991;8(6):503-6.
1991: M Suttorp; Norbert Schmitz; E Prange; Wolfgang Oster; Helmut Löffler; Jürgen Schaub; Arnold Ganser
Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3.
Leukemia 1991;5(8):723-5.
1991: H A Horst; Norbert Schmitz; C Glinike; H Löffler; R Laufs
Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.
The New England journal of medicine 1991;325(2):132-3.
1991: Winfried Gassmann; Lutz Uharek; A Erbersdobler; Bertram Glaß; H U Wottge; Norbert Schmitz; Helmut Löffler; W Mueller-Ruchholtz
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
British journal of haematology 1991;78(3):310-8.
1991: Norbert Schmitz; Brigitte Schlegelberger; K Oberböster; K Golchert; M Suttorp; Helmut Löffler
Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T-cell colonies, myeloid, and erythroid progenitor cells.
British journal of haematology 1991;78(3):334-42.
1991: Norbert Schmitz
[Possibilities and limits of bone marrow transplantation].
Krankenpflege (Frankfurt am Main, Germany) 1991;45(1):51-4.
1991: M Suttorp; Norbert Schmitz; E Prange; Arnold Ganser; Helmut Löffler; Jürgen Schaub
Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failure.
Bone marrow transplantation 1991;7 Suppl 2():84.
1990: Wolfgang Hiddemann; Norbert Schmitz; Michael Pfreundschuh; K H Pflüger; J Ollech-Chwoyka; C Tirier; Georg Maschmeyer; H Kirchner; T Wagner; P Koch
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Cancer 1990;66(5):838-43.
1990: Norbert Schmitz
[Allogeneic bone marrow transplantation in chronic myeloid leukemia. The results of HLA-identical transplants in the Federal Republic of Germany].
Deutsche medizinische Wochenschrift (1946) 1990;115(24):923-9.
1990: I Nölle; Brigitte Schlegelberger; Norbert Schmitz; S Bödewadt-Radzun; Werner Grote
Acute monocytic leukemia with translocation t(1;11) (p31;q23): simultaneous staining of chromosomes and cell surface antigens.
Haematology and blood transfusion 1990;33():145-9.
1989: D Niethammer; R Dopfer; T Klingebiel; H Riehm; G Schellong; G Henze; C Bender-Götze; R J Haas; Norbert Schmitz; W Friedrich
Actual role and perspectives of BMT in children.
Bone marrow transplantation 1989;4 Suppl 4():7-11.
1989: M Suttorp; Norbert Schmitz; S Leuschner; M Appelt; M Rister; Jürgen Schaub
Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
Bone marrow transplantation 1989;4 Suppl 4():144-8.
1989: W Gassmann; Norbert Schmitz; H U Wottge; H Löfler; W Müller-Ruchholtz
[Historical survey on the development of bone marrow transplantation].
Deutsche medizinische Wochenschrift (1946) 1989;114(28-29):1124-9.
1989: D Niethammer; R Dopfer; G Ehninger; U W Schäfer; B Stollmann; M Rister; Norbert Schmitz; C Bender-Götze; R J Haas; H Kolb
Bone marrow transplantation in childhood leukaemia--experience and strategies in the Federal Republic of Germany.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):361-6.
1988: Winfried Gassmann; Lutz Uharek; H U Wottge; Norbert Schmitz; Helmut Löffler; W Mueller-Ruchholtz
Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation.
Blood 1988;72(5):1574-9.
1988: Norbert Schmitz; Winfried Gassmann; M Rister; W Johannson; M Suttorp; F Brix; J J Holthuis; W Heit; B Hertenstein; Jürgen Schaub
Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias.
Blood 1988;72(5):1567-73.
1987: Norbert Schmitz; W Johannson; G Schmidt; K von der Helm; Helmut Löffler
Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6.
Blood 1987;70(4):1099-104.
1987: Hans Pralle; T Zwingers; S Boedewadt; K Bross; Bernd Dörken; H Gamm; Anthony Ho; R M Parwaresch; Norbert Schmitz; U Papendick
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
Leukemia 1987;1(4):337-40.
1987: W Kayser; K Spiegel; Norbert Schmitz; H Löffler
Application of a microseparation technique allowing for extensive marker studies on small bone marrow specimens.
Journal of immunological methods 1987;97(2):245-9.
1987: Norbert Schmitz; Winfried Gassmann; W Kayser; H Löffler
[Autologous bone marrow transplantation in Hodgkin's disease].
Deutsche medizinische Wochenschrift (1946) 1987;112(8):314-20.
1987: Hans Pralle; T Zwingers; S Boedewadt; K Bross; Bernd Dörken; H Gamm; Anthony Ho; R M Parwaresch; Norbert Schmitz; U Papendick
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Onkologie 1987;10(1):5-10.
1987: Winfried Gassmann; Norbert Schmitz; W Kayser; H Löffler
[Ultrahigh-dosage cytostatics--their possible use in acute leukemias?].
Deutsche medizinische Wochenschrift (1946) 1987;112(2):65-72.
1987: D Niethammer; G Ehninger; R Dopfer; P Ostendorf; H D Waller; Christine Bender-Götze; R J Haas; H J Kolb; G F Wündisch; Norbert Schmitz
Bone marrow transplantation in childhood leukemia in West Germany.
Haematology and blood transfusion 1987;30():217-25.
1987: Helmut Löffler; W Kayser; Norbert Schmitz; Eckhard Thiel; D Hoelzer; Thomas Büchner; D Urbanitz; K Spiegel; D Messerer; Achim Heinecke
Morphological and cytochemical classification of adult acute leukemias in two multicenter studies in the Federal Republic of Germany.
Haematology and blood transfusion 1987;30():21-7.
1986: W Gassmann; A Bikfalvi; Norbert Schmitz; H Löffler
[Intrathoracic involvement in Hodgkin's disease. Diagnosis--therapy--prognosis].
Praxis und Klinik der Pneumologie 1986;40(7):293-300.
1986: O Schröder; Norbert Schmitz; W Kayser; HH Euler; H Löffler
[Elevated cyclosporin A level during simultaneous therapy with danazol].
Deutsche medizinische Wochenschrift (1946) 1986;111(15):602-3.
1986: Norbert Schmitz; W Gassmann; H Löffler
[Clinical aspects of bone marrow transplantation].
Terapevticheskiĭ arkhiv 1986;58(9):18-23.
1985: W Kayser; HH Euler; Norbert Schmitz; Winfried Gassmann; H Löffler; F Asbeck
Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.
Blut 1985;51(6):401-4.
1985: Norbert Schmitz; W Kayser; Winfried Gassmann; HH Euler; M Wüstemann; F Brix; E Dühmke; Dieter Hebbinghaus; H Gremmel; Jürgen Schaub
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Deutsche medizinische Wochenschrift (1946) 1985;110(39):1488-93.
1985: Norbert Schmitz; W Gassmann; P Rautenberg; H Löffler
[Experiences with cytomegalovirus hyperimmunoglobulin after bone marrow transplantation].
Immunität und Infektion 1985;13(5):224-8.
1985: H H Euler; Norbert Schmitz; H Löffler
Plasmapheresis in paraproteinemia.
Blut 1985;50(6):321-30.
1985: Norbert Schmitz; E Gödde-Salz; H Löffler
Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation.
British journal of haematology 1985;60(2):239-44.
1985: W Gassmann; Hans Pralle; Torsten Haferlach; S Pandurevic; M Graubner; Norbert Schmitz; Helmut Löffler
Staging systems for multiple myeloma: a comparison.
British journal of haematology 1985;59(4):703-11.
1985: E Dühmke; F Brix; Dieter Hebbinghaus; M Jensen; Norbert Schmitz; H Wendhausen
[Fractionated homogeneous whole body irradiation prior to bone marrow transplantation].
Strahlentherapie 1985;161(3):134-9.
1985: Norbert Schmitz; P A Maubach; E Gödde-Salz; W Gassmann; H Löffler
Acute eosinophilic leukemia: characterization by cytochemistry, chromosomal analysis, and in vitro colony formation.
Klinische Wochenschrift 1985;63(3):133-7.
1985: W Gassmann; Norbert Schmitz; H Löffler
[Results of high-dose cytarabine therapy. A review].
Onkologie 1985;8(1):8-15.
1985: M J Anderson; Norbert Schmitz; H K Müller-Hermelink; W Müller-Ruchholtz
Selective antilymphocyte sera (SAL) in bone marrow transplantation. I. In vitro characterization of antihuman SAL and the development of absorption procedures using cultured cell lines.
International archives of allergy and applied immunology 1985;76(3):218-25.
1984: Winfried Gassmann; Norbert Schmitz; W Kayser; H Löffler
Hodgkin's disease.
Cancer treatment reviews 1984;11(4):311-4.
1984: Winfried Gassmann; T Haferlach; K H Engelhardt; G Rabenhorst; W Junge; Norbert Schmitz; W Kayser; HH Euler; H Löffler
[IgD plasmacytoma].
Deutsche medizinische Wochenschrift (1946) 1984;109(46):1775-9.
1984: W Gassmann; T Haferlach; Norbert Schmitz; W Kayser; HH Euler; J Drews; H Löffler
[Analysis of prognostic factors in plasmacytoma].
Klinische Wochenschrift 1984;62(19):896-905.
1984: Norbert Schmitz; Winfried Gassmann; W Kayser; H Löffler
[Chronic myelocytic leukemia: indication for bone marrow transplantation].
Deutsche medizinische Wochenschrift (1946) 1984;109(27):1074-7.
1984: Norbert Schmitz; E Gödde-Salz; W Gassmann; H Löffler
Acute myelomonocytic leukemia with involvement of eosinophils and inversion of chromosome 16.
Blut 1984;48(5):263-7.
1983: W Gassmann; T Haferlach; Norbert Schmitz; W Kayser; H Löffler
[Problems of intravenous urography in patients with plasmocytoma].
Schweizerische medizinische Wochenschrift 1983;113(8):301-4.
1983: H Löffler; W Gassmann; Norbert Schmitz
[Clinical course of acute leukemia].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1983;67():143-8.
1982: W Gassmann; Norbert Schmitz; H Löffler
[Virus etiology of Hodgkin's disease].
Deutsche medizinische Wochenschrift (1946) 1982;107(31-32):1171-2.
1982: W Gassmann; Norbert Schmitz; H Löffler
[10 years of DeVita protocol].
Deutsche medizinische Wochenschrift (1946) 1982;107(27):1043-4.
1982: W Gassmann; Norbert Schmitz; H Löffler
[The practice of chemotherapy with the DeVita protocol].
Deutsche medizinische Wochenschrift (1946) 1982;107(27):1063-9.
1982: W Gassmann; Norbert Schmitz; M Breidenbach; R Haas; G Barth; H Pralle; H Löffler
[Results of radiotherapy in case of Hodgkin's disease after primary failure of chemotherapy and recurrence after chemotherapy ].
Strahlentherapie 1982;158(6):336-41.
1982: Winfried Gassmann; L Perenyi; Norbert Schmitz; W Kayser; H Pralle; H Löffler
Prognostic factors in COPP-treated patients with Hodgkin's disease.
Blut 1982;44(6):339-48.
1982: Norbert Schmitz; W Kayser; Winfried Gassmann; A Hühn; G Krüger; V Sachs; H Löffler
Two cases of graft-versus-host disease following transfusion of nonirradiated blood products.
Blut 1982;44(2):83-8.
1982: Norbert Schmitz; W Gassmann; H Löffler
[Substitution with immunoglobulins in leukemia].
Beiträge zu Infusionstherapie und klinische Ernährung 1982;9():25-33.
1981: H Löffler; W Gassmann; Norbert Schmitz; H Pralle
[Current status of chemotherapy for Hodgkin's disease].
Die Medizinische Welt 1981;32(25):1010-6.
1981: W Gassmann; L Perenyi; H Pralle; M Graubner; Norbert Schmitz; H Löffler
[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].
Klinische Wochenschrift 1981;59(6):267-73.